During the trial, temporary leads are placed and connected to an external generator, allowing patients to experience firsthand the impact of neuromodulation on their chronic pain and related symptoms. Period to test device capabilities and capacity for pain relief. Prior to committing to full implantation of a neuromodulation device, patients undergo a trial Patients will be able to see information on their phone that would typically only be accessible in a doctor’s office – helping patients to share their journey with their doctors." "The launch of the NeuroSphere myPath is one more example of how Abbott has been leading the way in providing remote ways to connect doctors and patients. "The COVID-19 pandemic put a spotlight on the need for digital and remote health tools," said Keith Boettiger, vice president, Neuromodulation, Abbott. This new digital health app will allow patients to use their Apple mobile device to connect with Abbott support, access educational resources and track the progress of their trial pain relief journey. During the device trial period required before the permanent implant, the app allows patients to record their outcomes on pain and well-being while trialing their neurostimulation therapy.Ībbott’s NeuroSphere myPath is a digital innovation that will provide relief to the millions of Americans currently living with chronic pain that are eligible for SCS or DRG therapy. NeuroSphere myPath will be available in the Apple App Store in the coming weeks and will be compatible with the latest iOS operating systemĪbbott today announced the upcoming launch of NeuroSphere myPath, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with spinal cord stimulation (SCS) or dorsal root ganglion (DRG) therapy.New app will allow patients to record their pain relief during the device trial period with spinal cord stimulation or dorsal root ganglion therapy, simplify reporting outcomes and connect patients to physicians who have real-time access to this data.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |